Sponsor Pipeline

SHY Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
10
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07705334 A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic… Advanced or Metastatic Solid Tumors Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Prostate Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1) Gastric Cancer (1) Sarcoma (1) Mesothelioma (1)
Get alerts when SHY Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free